Skip to main content

Table 10 Baseline and other characteristics of the propensity score-matched patients receiving fondaparinux or enoxaparin (THA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

 

Fondaparinux

Enoxaparin

P value

n = 144

n = 144

Gender, male/female

20/124

23/121

0.620

Age, years

   

  Mean ± SD

67.3 ± 10.0

68.0 ± 8.8

0.707

  Range

40-87

44-86

 

Body mass index, kg/m2

   

  Mean ± SD

23.4 ± 3.8

23.8 ± 3.6

0.386

History of venous thrombosis, n (%)

-

-

 

malignant tumor

5 (3.5%)

0

0.030

Comorbidities, n (%)

   

  Hypertension

59 (41.0%)

54 (37.5%)

0.546

  Ischemic heart disease

7 (4.9%)

6 (4.2%)

0.777

  Diabetes

11 (7.6%)

10 (6.9%)

0.821

  Cerebrovascular disease

4 (2.8%)

3 (2.1%)

0.702

Operation time, minutes

   

  Mean ± SD

124.6 ± 38.7

125.6 ± 47.3

0.931

Primary diseases, n (%)

   

  Rheumatoid arthritis

9 (6.3%)

5 (3.5%)

0.273

  Osteoarthritis

129 (89.6%)

129 (89.6%)

1.000

  Others

6 (4.2%)

10 (6.9%)

0.303

General anesthesia

141 (97.9%)

141 (97.9%)

1.000

Use of elastic stocking, n (%)

131 (91.0%)

133 (92.4%)

0.670

Use of foot pump, n (%)

138 (95.8%)

137 (95.1%)

0.777

Use of cement, n (%)

23 (16.0%)

24 (16.7%)

0.873

e-GFR, mL/min per 1.73 m2

   

  Mean ± SD

81.9 ± 20.0

78.6 ± 16.8

0.220

  Range

29.0-139.0

37.7-128.9

 

Serum albumin, g/dL

   

  Mean ± SD

4.0 ± 0.5

4.1 ± 0.4

0.001

  Range

2.4-5.0

2.6-5.1

 

Platelet count, 104/μL

   

  Mean ± SD

27.7 ± 7.6

26.0 ± 7.7

0.048

  1. Kruskal-Wallis rank test were performed on the means of continuous variables. For categorical variables, chi-squared tests were used. e-GFR, estimated glomerular filtrating ratio; SD, standard deviation; THA, total hip arthroplasty.